IL-1β and IL-6 are key drivers of endothelial dysfunction and plaque destabilization, while TNF-α is involved in amplifying the inflammatory cascade and enhancing cellular adhesion, making them particularly relevant therapeutic targets. Here, IL1B is linked to endothelial dysfunction.